Target-Based Antimicrobial Drug Discovery - Bacterial Pathogenesis: Methods and Protocols - page 266

33. Alksne, L. E. and Projan, S. J. (2000) Bacterial virulence as a target for
antimicrobial chemotherapy.[erratum appears in Curr. Opin. Biotechnol . 2001
Feb;12(1):112]. Curr. Opin. Biotechnol . 11 , 625-636.
34. Otto, M. (2004) Quorum-sensing control in Staphylococci - a target for antimi-
crobial drug therapy? FEMS Microbiol. Lett . 241 , 135-141.
35. Nordfelth, R., Kauppi, A. M., Norberg, H. A., Wolf-Watz, H., and Elofsson, M.
(2005) Small-molecule inhibitors specifically targeting type III secretion. Infect.
Immun . 73 , 3104-3114.
36. Posner, B. A. (2005) High-throughput screening-driven lead discovery: meeting the
challenges of finding new therapeutics. Curr. Opin. Drug Discov. Dev . 8 , 487-494.
37. Goddard, J. -P. and Reymond, J. -L. (2004) Enzyme assays for high-throughput
screening. Curr. Opin. Biotechnol . 15 , 314-322.
38. Allison, R. D. (1997) Kinetic assay methods in Current Protocols in Molecular
Biology , Supplement 40, Appendix 3H, John Wiley & Sons, Inc., pp. A.3H.
1-A.3H.10.
39. Lipinski, C. A. (2000) Drug-like properties and the causes of poor solubility and
poor permeability. J. Pharmacol. Toxicol. Methods 44 , 235-249.
40. Donadio, S., Carrano, L., Brandi, L., Serina, S., Soffientini, A., Raimondi, E.,
Montanini, N., Sosio, M., and Gualerzi, C. O. (2002) Targets and assays for
discovering novel antibacterial agents. J. Biotechnol . 99 , 175-185.
41. Thomson, C. J., Power, E., Ruebsamen-Waigmann, H., and Labischinski, H.
(2004) Antibacterial research and development in the 21(st) Century-an industry
perspective of the challenges. Curr. Opin. Microbiol . 7 , 445-450.
42. Lundqvist, T. (2005) The devil is still in the details-driving early drug discovery
forward with biophysical experimental methods. Curr. Opin. Drug Discov. Devel .
8 , 513-519.
43. Mills, S. D. (2006) When will the genomics investment pay off for antibacterial
discovery? Biochem. Pharmacol . 71 , 1096-1102.
44. Krumrine, J., Raubacher, F., Brooijmans, N., and Kuntz, I. (2003) Principles and
methods of docking and ligand design, in Structural Bioinformatics (Weissig, H.
and Bourne, P. E., eds.), Wiley, Indianapolis, IN, pp. 441-476.
45. Schmid, M. B. (2004) Seeing is believing: the impact of structural genomics on
antimicrobial drug discovery. Nat. Rev. Microbiol . 2 , 739-746.
46. Poole, K. (2004) Uninhibited antibiotic target discovery via chemical genetics.
Nat. Biotechnol . 22 , 1528-1529.
47. Li, X., Zolli-Juran, M., Cechetto, J. D., Daigle, D. M., Wright, G. D., and
Brown, E. D. (2004) Multicopy suppressors for novel antibacterial compounds
reveal targets and drug efflux susceptibility. Chem. Biol . 11 , 1423-1430.
48. Singh, S. B. and Barrett, J. F. (2006) Empirical antibacterial drug discovery-
foundation in natural products. Biochem. Pharmacol . 71 , 1006-1015.